GoodRx Holdings, Inc. (GDRX) Tops Q1 EPS by 1c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
GoodRx Holdings Inc. (GDRX) PT Lowered to $8 at Deutsche Bank
May 13, 2024 5:49 AM EDTDeutsche Bank analyst George Hill lowered the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $8.00 (from $9.00) while maintaining a Hold rating.
The analyst comments "Modest Q1 Beat With Continued Margin Expansion: GDRX reported solid Q1 results with modest revenue beat and better-than-expected... More
TD Cowen Reiterates Buy Rating on GoodRx Holdings Inc. (GDRX)
May 9, 2024 4:01 PM EDTTD Cowen analyst Charles Rhyee reiterated a Buy rating and $14.00 price target on GoodRx Holdings Inc. (NASDAQ: GDRX)
The analyst comments "We update our model following 1Q24 results, where mgmt. raised its 2024 guidance for revenue to $800-$810M (from ~$800M) and adj.... More
